 | • レポートコード：QYR2104Z3298 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、IVF（体外受精）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（卵細胞質内精子注入法（ICSI）、凍結胚置換（FER）、着床前遺伝子診断（PGD））、用途別市場規模（クローン、トランスジェニック、胚性幹細胞分離・培養、試験管ベビー）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・IVF（体外受精）の市場動向 ・企業の競争状況、市場シェア ・IVF（体外受精）の種類別市場規模（卵細胞質内精子注入法（ICSI）、凍結胚置換（FER）、着床前遺伝子診断（PGD）） ・IVF（体外受精）の用途別市場規模（クローン、トランスジェニック、胚性幹細胞分離・培養、試験管ベビー） ・IVF（体外受精）の北米市場規模2016-2027（アメリカ、カナダ） ・IVF（体外受精）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・IVF（体外受精）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・IVF（体外受精）の中南米市場規模2016-2027（メキシコ、ブラジル） ・IVF（体外受精）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Vitrolife AB、EMD Serono Inc、Irvine scientific、Cooper Surgical Inc、Cook Medical Inc、Thermo Fisher Scientific Inc、Genea Biomedx、Auxogyn, Inc、Oxford Gene Technology、Ovascience） ・結論 |
In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm outside the body, in vitro (“in glass”). The process involves monitoring and stimulating a woman’s ovulatory process, removing an ovum or ova (egg or eggs) from the woman’s ovaries and letting sperm fertilise them in a liquid in a laboratory. The fertilised egg (zygote) undergoes embryo culture for 2–6 days, and is then transferred to the same or another woman’s uterus, with the intention of establishing a successful pregnancy.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for IVF in US$ by following Product Segments.: Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER) and Pre-implantation Genetic Diagnosis (PGD)
Company profiles are primarily based on public domain information including company
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience
Market Analysis and Insights: Global IVF Market
The global IVF market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IVF market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IVF market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IVF market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IVF market.
Global IVF Scope and Market Size
IVF market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IVF market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Intracytoplasmic Sperm Injection (ICSI)
Frozen Embryo Replacement (FER)
Pre-implantation Genetic Diagnosis (PGD)
Segment by Application
Clone
Transgenic
Embryonic Stem Cell Isolation and Culture
Test Tube Baby
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVF Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intracytoplasmic Sperm Injection (ICSI)
1.2.3 Frozen Embryo Replacement (FER)
1.2.4 Pre-implantation Genetic Diagnosis (PGD)
1.3 Market by Application
1.3.1 Global IVF Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clone
1.3.3 Transgenic
1.3.4 Embryonic Stem Cell Isolation and Culture
1.3.5 Test Tube Baby
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global IVF Market Perspective (2016-2027)
2.2 IVF Growth Trends by Regions
2.2.1 IVF Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 IVF Historic Market Share by Regions (2016-2021)
2.2.3 IVF Forecasted Market Size by Regions (2022-2027)
2.3 IVF Industry Dynamic
2.3.1 IVF Market Trends
2.3.2 IVF Market Drivers
2.3.3 IVF Market Challenges
2.3.4 IVF Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVF Players by Revenue
3.1.1 Global Top IVF Players by Revenue (2016-2021)
3.1.2 Global IVF Revenue Market Share by Players (2016-2021)
3.2 Global IVF Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by IVF Revenue
3.4 Global IVF Market Concentration Ratio
3.4.1 Global IVF Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVF Revenue in 2020
3.5 IVF Key Players Head office and Area Served
3.6 Key Players IVF Product Solution and Service
3.7 Date of Enter into IVF Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVF Breakdown Data by Type
4.1 Global IVF Historic Market Size by Type (2016-2021)
4.2 Global IVF Forecasted Market Size by Type (2022-2027)
5 IVF Breakdown Data by Application
5.1 Global IVF Historic Market Size by Application (2016-2021)
5.2 Global IVF Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America IVF Market Size (2016-2027)
6.2 North America IVF Market Size by Type
6.2.1 North America IVF Market Size by Type (2016-2021)
6.2.2 North America IVF Market Size by Type (2022-2027)
6.2.3 North America IVF Market Size by Type (2016-2027)
6.3 North America IVF Market Size by Application
6.3.1 North America IVF Market Size by Application (2016-2021)
6.3.2 North America IVF Market Size by Application (2022-2027)
6.3.3 North America IVF Market Size by Application (2016-2027)
6.4 North America IVF Market Size by Country
6.4.1 North America IVF Market Size by Country (2016-2021)
6.4.2 North America IVF Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe IVF Market Size (2016-2027)
7.2 Europe IVF Market Size by Type
7.2.1 Europe IVF Market Size by Type (2016-2021)
7.2.2 Europe IVF Market Size by Type (2022-2027)
7.2.3 Europe IVF Market Size by Type (2016-2027)
7.3 Europe IVF Market Size by Application
7.3.1 Europe IVF Market Size by Application (2016-2021)
7.3.2 Europe IVF Market Size by Application (2022-2027)
7.3.3 Europe IVF Market Size by Application (2016-2027)
7.4 Europe IVF Market Size by Country
7.4.1 Europe IVF Market Size by Country (2016-2021)
7.4.2 Europe IVF Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific IVF Market Size (2016-2027)
8.2 Asia-Pacific IVF Market Size by Type
8.2.1 Asia-Pacific IVF Market Size by Type (2016-2021)
8.2.2 Asia-Pacific IVF Market Size by Type (2022-2027)
8.2.3 Asia-Pacific IVF Market Size by Type (2016-2027)
8.3 Asia-Pacific IVF Market Size by Application
8.3.1 Asia-Pacific IVF Market Size by Application (2016-2021)
8.3.2 Asia-Pacific IVF Market Size by Application (2022-2027)
8.3.3 Asia-Pacific IVF Market Size by Application (2016-2027)
8.4 Asia-Pacific IVF Market Size by Region
8.4.1 Asia-Pacific IVF Market Size by Region (2016-2021)
8.4.2 Asia-Pacific IVF Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America IVF Market Size (2016-2027)
9.2 Latin America IVF Market Size by Type
9.2.1 Latin America IVF Market Size by Type (2016-2021)
9.2.2 Latin America IVF Market Size by Type (2022-2027)
9.2.3 Latin America IVF Market Size by Type (2016-2027)
9.3 Latin America IVF Market Size by Application
9.3.1 Latin America IVF Market Size by Application (2016-2021)
9.3.2 Latin America IVF Market Size by Application (2022-2027)
9.3.3 Latin America IVF Market Size by Application (2016-2027)
9.4 Latin America IVF Market Size by Country
9.4.1 Latin America IVF Market Size by Country (2016-2021)
9.4.2 Latin America IVF Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVF Market Size (2016-2027)
10.2 Middle East & Africa IVF Market Size by Type
10.2.1 Middle East & Africa IVF Market Size by Type (2016-2021)
10.2.2 Middle East & Africa IVF Market Size by Type (2022-2027)
10.2.3 Middle East & Africa IVF Market Size by Type (2016-2027)
10.3 Middle East & Africa IVF Market Size by Application
10.3.1 Middle East & Africa IVF Market Size by Application (2016-2021)
10.3.2 Middle East & Africa IVF Market Size by Application (2022-2027)
10.3.3 Middle East & Africa IVF Market Size by Application (2016-2027)
10.4 Middle East & Africa IVF Market Size by Country
10.4.1 Middle East & Africa IVF Market Size by Country (2016-2021)
10.4.2 Middle East & Africa IVF Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Vitrolife AB
11.1.1 Vitrolife AB Company Details
11.1.2 Vitrolife AB Business Overview
11.1.3 Vitrolife AB IVF Introduction
11.1.4 Vitrolife AB Revenue in IVF Business (2016-2021)
11.1.5 Vitrolife AB Recent Development
11.2 EMD Serono Inc
11.2.1 EMD Serono Inc Company Details
11.2.2 EMD Serono Inc Business Overview
11.2.3 EMD Serono Inc IVF Introduction
11.2.4 EMD Serono Inc Revenue in IVF Business (2016-2021)
11.2.5 EMD Serono Inc Recent Development
11.3 Irvine scientific
11.3.1 Irvine scientific Company Details
11.3.2 Irvine scientific Business Overview
11.3.3 Irvine scientific IVF Introduction
11.3.4 Irvine scientific Revenue in IVF Business (2016-2021)
11.3.5 Irvine scientific Recent Development
11.4 Cooper Surgical Inc
11.4.1 Cooper Surgical Inc Company Details
11.4.2 Cooper Surgical Inc Business Overview
11.4.3 Cooper Surgical Inc IVF Introduction
11.4.4 Cooper Surgical Inc Revenue in IVF Business (2016-2021)
11.4.5 Cooper Surgical Inc Recent Development
11.5 Cook Medical Inc
11.5.1 Cook Medical Inc Company Details
11.5.2 Cook Medical Inc Business Overview
11.5.3 Cook Medical Inc IVF Introduction
11.5.4 Cook Medical Inc Revenue in IVF Business (2016-2021)
11.5.5 Cook Medical Inc Recent Development
11.6 Thermo Fisher Scientific Inc
11.6.1 Thermo Fisher Scientific Inc Company Details
11.6.2 Thermo Fisher Scientific Inc Business Overview
11.6.3 Thermo Fisher Scientific Inc IVF Introduction
11.6.4 Thermo Fisher Scientific Inc Revenue in IVF Business (2016-2021)
11.6.5 Thermo Fisher Scientific Inc Recent Development
11.7 Genea Biomedx
11.7.1 Genea Biomedx Company Details
11.7.2 Genea Biomedx Business Overview
11.7.3 Genea Biomedx IVF Introduction
11.7.4 Genea Biomedx Revenue in IVF Business (2016-2021)
11.7.5 Genea Biomedx Recent Development
11.8 Auxogyn, Inc
11.8.1 Auxogyn, Inc Company Details
11.8.2 Auxogyn, Inc Business Overview
11.8.3 Auxogyn, Inc IVF Introduction
11.8.4 Auxogyn, Inc Revenue in IVF Business (2016-2021)
11.8.5 Auxogyn, Inc Recent Development
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Details
11.9.2 Oxford Gene Technology Business Overview
11.9.3 Oxford Gene Technology IVF Introduction
11.9.4 Oxford Gene Technology Revenue in IVF Business (2016-2021)
11.9.5 Oxford Gene Technology Recent Development
11.10 Ovascience
11.10.1 Ovascience Company Details
11.10.2 Ovascience Business Overview
11.10.3 Ovascience IVF Introduction
11.10.4 Ovascience Revenue in IVF Business (2016-2021)
11.10.5 Ovascience Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global IVF Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intracytoplasmic Sperm Injection (ICSI)
Table 3. Key Players of Frozen Embryo Replacement (FER)
Table 4. Key Players of Pre-implantation Genetic Diagnosis (PGD)
Table 5. Global IVF Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global IVF Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global IVF Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global IVF Market Share by Regions (2016-2021)
Table 9. Global IVF Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global IVF Market Share by Regions (2022-2027)
Table 11. IVF Market Trends
Table 12. IVF Market Drivers
Table 13. IVF Market Challenges
Table 14. IVF Market Restraints
Table 15. Global IVF Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global IVF Market Share by Players (2016-2021)
Table 17. Global Top IVF Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVF as of 2020)
Table 18. Ranking of Global Top IVF Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by IVF Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players IVF Product Solution and Service
Table 22. Date of Enter into IVF Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global IVF Market Size by Type (2016-2021) (US$ Million)
Table 25. Global IVF Revenue Market Share by Type (2016-2021)
Table 26. Global IVF Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global IVF Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global IVF Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global IVF Revenue Market Share by Application (2016-2021)
Table 30. Global IVF Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global IVF Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America IVF Market Size by Type (2016-2021) (US$ Million)
Table 33. North America IVF Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America IVF Market Size by Application (2016-2021) (US$ Million)
Table 35. North America IVF Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America IVF Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America IVF Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe IVF Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe IVF Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe IVF Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe IVF Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe IVF Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe IVF Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific IVF Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific IVF Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific IVF Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific IVF Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific IVF Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific IVF Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America IVF Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America IVF Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America IVF Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America IVF Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America IVF Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America IVF Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa IVF Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa IVF Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa IVF Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa IVF Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa IVF Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa IVF Market Size by Country (2022-2027) & (US$ Million)
Table 62. Vitrolife AB Company Details
Table 63. Vitrolife AB Business Overview
Table 64. Vitrolife AB IVF Product
Table 65. Vitrolife AB Revenue in IVF Business (2016-2021) & (US$ Million)
Table 66. Vitrolife AB Recent Development
Table 67. EMD Serono Inc Company Details
Table 68. EMD Serono Inc Business Overview
Table 69. EMD Serono Inc IVF Product
Table 70. EMD Serono Inc Revenue in IVF Business (2016-2021) & (US$ Million)
Table 71. EMD Serono Inc Recent Development
Table 72. Irvine scientific Company Details
Table 73. Irvine scientific Business Overview
Table 74. Irvine scientific IVF Product
Table 75. Irvine scientific Revenue in IVF Business (2016-2021) & (US$ Million)
Table 76. Irvine scientific Recent Development
Table 77. Cooper Surgical Inc Company Details
Table 78. Cooper Surgical Inc Business Overview
Table 79. Cooper Surgical Inc IVF Product
Table 80. Cooper Surgical Inc Revenue in IVF Business (2016-2021) & (US$ Million)
Table 81. Cooper Surgical Inc Recent Development
Table 82. Cook Medical Inc Company Details
Table 83. Cook Medical Inc Business Overview
Table 84. Cook Medical Inc IVF Product
Table 85. Cook Medical Inc Revenue in IVF Business (2016-2021) & (US$ Million)
Table 86. Cook Medical Inc Recent Development
Table 87. Thermo Fisher Scientific Inc Company Details
Table 88. Thermo Fisher Scientific Inc Business Overview
Table 89. Thermo Fisher Scientific Inc IVF Product
Table 90. Thermo Fisher Scientific Inc Revenue in IVF Business (2016-2021) & (US$ Million)
Table 91. Thermo Fisher Scientific Inc Recent Development
Table 92. Genea Biomedx Company Details
Table 93. Genea Biomedx Business Overview
Table 94. Genea Biomedx IVF Product
Table 95. Genea Biomedx Revenue in IVF Business (2016-2021) & (US$ Million)
Table 96. Genea Biomedx Recent Development
Table 97. Auxogyn, Inc Company Details
Table 98. Auxogyn, Inc Business Overview
Table 99. Auxogyn, Inc Revenue in IVF Business (2016-2021) & (US$ Million)
Table 100. Auxogyn, Inc Recent Development
Table 101. Oxford Gene Technology Company Details
Table 102. Oxford Gene Technology Business Overview
Table 103. Oxford Gene Technology IVF Product
Table 104. Oxford Gene Technology Revenue in IVF Business (2016-2021) & (US$ Million)
Table 105. Oxford Gene Technology Recent Development
Table 106. Ovascience Company Details
Table 107. Ovascience Business Overview
Table 108. Ovascience IVF Product
Table 109. Ovascience Revenue in IVF Business (2016-2021) & (US$ Million)
Table 110. Ovascience Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVF Market Share by Type: 2020 VS 2027
Figure 2. Intracytoplasmic Sperm Injection (ICSI) Features
Figure 3. Frozen Embryo Replacement (FER) Features
Figure 4. Pre-implantation Genetic Diagnosis (PGD) Features
Figure 5. Global IVF Market Share by Application: 2020 VS 2027
Figure 6. Clone Case Studies
Figure 7. Transgenic Case Studies
Figure 8. Embryonic Stem Cell Isolation and Culture Case Studies
Figure 9. Test Tube Baby Case Studies
Figure 10. IVF Report Years Considered
Figure 11. Global IVF Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global IVF Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global IVF Market Share by Regions: 2020 VS 2027
Figure 14. Global IVF Market Share by Regions (2022-2027)
Figure 15. Global IVF Market Share by Players in 2020
Figure 16. Global Top IVF Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVF as of 2020
Figure 17. The Top 10 and 5 Players Market Share by IVF Revenue in 2020
Figure 18. Global IVF Revenue Market Share by Type (2016-2021)
Figure 19. Global IVF Revenue Market Share by Type (2022-2027)
Figure 20. North America IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America IVF Market Share by Type (2016-2027)
Figure 22. North America IVF Market Share by Application (2016-2027)
Figure 23. North America IVF Market Share by Country (2016-2027)
Figure 24. United States IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe IVF Market Share by Type (2016-2027)
Figure 28. Europe IVF Market Share by Application (2016-2027)
Figure 29. Europe IVF Market Share by Country (2016-2027)
Figure 30. Germany IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific IVF Market Share by Type (2016-2027)
Figure 38. Asia-Pacific IVF Market Share by Application (2016-2027)
Figure 39. Asia-Pacific IVF Market Share by Region (2016-2027)
Figure 40. China IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America IVF Market Share by Type (2016-2027)
Figure 48. Latin America IVF Market Share by Application (2016-2027)
Figure 49. Latin America IVF Market Share by Country (2016-2027)
Figure 50. Mexico IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa IVF Market Share by Type (2016-2027)
Figure 54. Middle East & Africa IVF Market Share by Application (2016-2027)
Figure 55. Middle East & Africa IVF Market Share by Country (2016-2027)
Figure 56. Turkey IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE IVF Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Vitrolife AB Revenue Growth Rate in IVF Business (2016-2021)
Figure 60. EMD Serono Inc Revenue Growth Rate in IVF Business (2016-2021)
Figure 61. Irvine scientific Revenue Growth Rate in IVF Business (2016-2021)
Figure 62. Cooper Surgical Inc Revenue Growth Rate in IVF Business (2016-2021)
Figure 63. Cook Medical Inc Revenue Growth Rate in IVF Business (2016-2021)
Figure 64. Thermo Fisher Scientific Inc Revenue Growth Rate in IVF Business (2016-2021)
Figure 65. Genea Biomedx Revenue Growth Rate in IVF Business (2016-2021)
Figure 66. Auxogyn, Inc Revenue Growth Rate in IVF Business (2016-2021)
Figure 67. Oxford Gene Technology Revenue Growth Rate in IVF Business (2016-2021)
Figure 68. Ovascience Revenue Growth Rate in IVF Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の着床前遺伝子診断（PGD）市場規模・現状・予測（2021年-2027年） Pre-Implantation Genetic Diagnosis (PGD) is the genetic profiling of embryos prior to implantation (as a form of embryo profiling), and sometimes even of oocytes prior to fertilization. When used to screen for a specific genetic disease, PGD main advantage is that it avoids selective abortion, as th…- 世界の体外受精（IVF）装置市場 2021：企業別、地域別、種類・用途別 The In-Vitro Fertilization (IVF) Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のヒト胚性幹細胞アッセイ市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Embryonic Stem Cell Assay Market The global Human Embryonic Stem Cell Assay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
- 世界の細胞単離技術市場規模・現状・予測（2021年-2027年） Cell separation technology is the basic means of studying such as the nucleus, mitochondria, Golgi, lysosomes and microsomes, as well as various macromolecules. Differential centrifugation is used to separate cells and organelles of different sizes. Flow cytometry is a technique for rapid quantitati…
- 世界の自家幹細胞ベース治療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…